OpenEvidence launches new family of AI models
4 September 2026 · filed under 5279eb8154cf
On September 3, STAT News reported that OpenEvidence has launched a new family of AI models, per its Health Tech edition of that date. The report, credited to STAT News and published at 13:18 UTC, situates the launch alongside coverage of the FDA’s TEMPO pilot and what it signals for AI regulation.
The provided summary describes the edition’s scope as covering the TEMPO pilot’s regulatory implications, the OpenEvidence model launch, and additional items grouped under the same STAT Health Tech dispatch. Beyond confirming the launch itself and its date of report, the supplied material does not detail the technical composition of the new model family, its intended clinical applications, or how it differs from OpenEvidence’s prior offerings.
The full STAT+ article, linked at statnews.com, is behind STAT’s subscription paywall, and this Bulletin has not had access to its complete text. Readers seeking specifics on the models’ architecture, training data, or regulatory posture should consult the original STAT+ report directly.
No independent confirmation of the launch details beyond the STAT News summary is available from the sources provided. This Bulletin restricts itself to what STAT News has reported: that OpenEvidence has introduced new AI models, and that the announcement appears in the same edition addressing FDA’s TEMPO pilot.